Search for: "Mylan Pharmaceuticals" Results 561 - 580 of 739
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
19 Apr 2010, 11:39 am by Phillips & Cohen
It details the activities and successes of NY's MFCU.The report highlights Operation Home Alone, an investigation of corruption in the home care industry; settlements with several pharmaceutical companies, including Eli Lilly, Pfizer, Mylan Pharmaceuticals, Astra Zeneca, and Aventis for off-label marketing, kickbacks, misreporting prices, and other fraud; nursing home fraud investigations; and other types of program fraud. [read post]
15 Apr 2010, 9:20 am by Bexis
Cir. 1996) (not an FDCA case); Mylan Laboratories, Inc. v. [read post]
15 Apr 2010, 4:27 am
You can separately subscribe to the IP Think Tank Global Week in Review at the Subscribe page: http://thinkipstrategy.com/subscribe/   Highlights this week included: CAFC denies Vanderbilt’s claim to Cialis patent right: Vanderbilt University v ICOS Corporation (Patently-O) (IPBiz) Paris District Court: Basic patent for Losartan covers any product comprising Losartan: Du Pont v Mylan Losartan SPC case (EPLAW)   General WHO documents from counterfeit meeting now online (IP… [read post]
11 Apr 2010, 9:36 pm by Patent Docs
• Defendant: Mylan Pharmaceuticals Inc. [read post]
9 Apr 2010, 8:30 am by Lucas A. Ferrara, Esq.
These companies include Mylan Pharmaceuticals Inc., Roxane Laboratories Inc., and Torrent Pharmaceuticals Ltd. [read post]
31 Mar 2010, 1:58 pm
Pressure Products Medical Supplies invented a valve remover for an introducer, netting 5,125,904 & 5,312,355. [read post]
3 Mar 2010, 5:05 am
(IP Osgoode) Australia: University of Western Australia’s application to appeal FCAFC’s decision in University of Western Australia v Gray fails (IP Whiteboard) Colombia/EU/Peru: Tough IP health provisions in Europe’s Colombia/Peru trade deal (IP Watch) (IP tango) EU: Something more about Swiss type claims: G02/08 (SiNApSE) (SiNApSE) US: Pharmaceutical patent settlements – and what about patients? [read post]
3 Mar 2010, 5:05 am
(IP Osgoode) Australia: University of Western Australia’s application to appeal FCAFC’s decision in University of Western Australia v Gray fails (IP Whiteboard) Colombia/EU/Peru: Tough IP health provisions in Europe’s Colombia/Peru trade deal (IP Watch) (IP tango) EU: Something more about Swiss type claims: G02/08 (SiNApSE) (SiNApSE) US: Pharmaceutical patent settlements – and what about patients? [read post]
17 Feb 2010, 5:10 am
Trigen Laboratories, Inc (Patent Docs) Tramadol – France: Preliminary injunctions in case of an ‘imminent infringement’: Mylan v Medochemie (EPLAW)   [read post]
3 Feb 2010, 2:00 am
Barr Laboratories, Inc. and Mylan Pharma (Patent Docs) (Patently-O) EU: ‘Victory’ against biopiracy - EPO revokes Schwabe Pharmaceuticals' pelargonium extract patent (Spicy IP) (IP Watch)   General Another case for indigenous knowledge protection, but how? [read post]
27 Jan 2010, 9:20 pm by Walter Olson
District Judge Joseph Goodwin plans to punish lawyers who filed worthless claims against Mylan Pharmaceuticals and Actavis Totowa. [read post]
27 Jan 2010, 9:09 pm by Walter Olson
District Judge Joseph Goodwin plans to punish lawyers who filed worthless claims against Mylan Pharmaceuticals and Actavis Totowa. [read post]
27 Jan 2010, 9:04 pm by Patent Docs
District Court for the District of Delaware has ruled that Bristol-Myers Squibb may proceed with its patent infringement suit against defendants Mylan Pharmaceuticals and Matrix Laboratories over Bristol-Myers' patent covering the HIV treatment Sustiva®, U.S. [read post]